Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E N Spremulli

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1984
Polar solvents: a novel class of antineoplastic agentsE N Spremulli, D L Dexter
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1983
Human tumor cell heterogeneity and metastasisE N Spremulli, D L Dexter
Cancer Treatment Reports|October 1, 1986
Randomized comparison of tamoxifen versus diethylstilbestrol in estrogen receptor-positive or -unknown metastatic breast cancer: a Southeastern Cancer Study Group trialJ P Gockerman, E N Spremulli, M Raney, et al.
Cancer Research|December 1, 1982
Inhibition of the growth of human colon cancer xenografts by polar solventsD L Dexter, E N Spremulli, G M Matook, et al.
Journal of Analytical Toxicology|May 1, 1984
Tissue analysis of N-methylformamide: organ distributionG M Matook, E N Spremulli, B K Birmingham, et al.
Journal of the National Cancer Institute|March 1, 1983
Hemodynamic effects of potentially useful antineoplastic agentsE N Spremulli, F J Cummings, G W Crabtree, et al.
The American Journal of Medicine|December 1, 1981
Heterogeneity of cancer cells from a single human colon carcinomaD L Dexter, E N Spremulli, Z Fligiel, et al.
Cancer Research|April 1, 1983
Selection of metastatic variants from heterogeneous tumor cell lines using the chicken chorioallantoic membrane and nude mouseD L Dexter, E S Lee, D J DeFusco, et al.
Clinical Pharmacology and Therapeutics|November 1, 1988
Clinical, pharmacologic, and immunologic effects of 2'-deoxycoformycinF J Cummings, G W Crabtree, M C Wiemann, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1988
Phase I trial of the combination of 6-methylmercaptopurine riboside and 5-fluorouracilM C Wiemann, G W Crabtree, A B Weitberg, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1984
Polar solvents: a novel class of antineoplastic agentsE N Spremulli, D L Dexter
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1983
Human tumor cell heterogeneity and metastasisE N Spremulli, D L Dexter
Cancer Treatment Reports|October 1, 1986
Randomized comparison of tamoxifen versus diethylstilbestrol in estrogen receptor-positive or -unknown metastatic breast cancer: a Southeastern Cancer Study Group trialJ P Gockerman, E N Spremulli, M Raney, et al.
Cancer Research|December 1, 1982
Inhibition of the growth of human colon cancer xenografts by polar solventsD L Dexter, E N Spremulli, G M Matook, et al.
Journal of Analytical Toxicology|May 1, 1984
Tissue analysis of N-methylformamide: organ distributionG M Matook, E N Spremulli, B K Birmingham, et al.
Journal of the National Cancer Institute|March 1, 1983
Hemodynamic effects of potentially useful antineoplastic agentsE N Spremulli, F J Cummings, G W Crabtree, et al.
The American Journal of Medicine|December 1, 1981
Heterogeneity of cancer cells from a single human colon carcinomaD L Dexter, E N Spremulli, Z Fligiel, et al.
Cancer Research|April 1, 1983
Selection of metastatic variants from heterogeneous tumor cell lines using the chicken chorioallantoic membrane and nude mouseD L Dexter, E S Lee, D J DeFusco, et al.
Clinical Pharmacology and Therapeutics|November 1, 1988
Clinical, pharmacologic, and immunologic effects of 2'-deoxycoformycinF J Cummings, G W Crabtree, M C Wiemann, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1988
Phase I trial of the combination of 6-methylmercaptopurine riboside and 5-fluorouracilM C Wiemann, G W Crabtree, A B Weitberg, et al.
Pageof 2